IPO Boutique

ACELYRIN, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on ACELYRIN, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
ACELYRIN, Inc.SLRN -
NASDAQ
30 million $18.00 $23.00$16.00-$18.005/5/2023
Morgan Stanley, Jefferies, TD Cowen, Piper Sandler
Co-Manager(s):
Health Care
Filing(s):

Filed 2023-04-13
Terms Added 2023-05-01
Amended Prospectus 2023-05-03



ACELYRIN, Inc. Quote & Chart - Click for current quote - SLRN

About ACELYRIN, Inc. (adapted from ACELYRIN, Inc. prospectus):
ACELYRIN is a late-stage clinical biopharma company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "SLRN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved